European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis.
about
A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysisThe ins and outs of RND efflux pumps in Escherichia coliInsights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanismsThe role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.Susceptibility of urinary tract bacteria to fosfomycinEscherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients.High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen?Food reservoir for Escherichia coli causing urinary tract infections.Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis.Escherichia coli ST131, an intriguing clonal groupPopulation structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England.Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.Diversity and biofilm-production ability among isolates of Escherichia coli phylogroup D belonging to ST69, ST393 and ST405 clonal groups.Molecular epidemiological characterization of uropathogenic escherichia coli from an outpatient urology clinic in rural JapanExtraintestinal Pathogenic and Antimicrobial-Resistant Escherichia coli Contamination of 56 Public Restrooms in the Greater Minneapolis-St. Paul Metropolitan Area.Risk factors for infection following prostate biopsy - a case control study.High metabolic potential may contribute to the success of ST131 uropathogenic Escherichia coliGlobal fluoroquinolone resistance epidemiology and implictions for clinical use.Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countriesIncidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota.Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification.Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coliAbrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.Uncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic AspectsHost-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.Three-decade epidemiological analysis of Escherichia coli O15:K52:H1.Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections.Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women.Trends in ExPEC serogroups in the UK and their significance.The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center.Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern communityEscherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts.Association between antimicrobial resistance and virulence in Escherichia coli.Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.
P2860
Q27011287-F8F5C429-6950-4DED-8F05-10FA7F17EE2DQ28073332-A7776950-53A1-4BE0-9D30-2FDA2CC97B2EQ28084596-E8CD79E4-3A19-411B-AD5D-3892C3E0EC75Q28477685-977D54C9-9F79-48C2-8ACC-0752B66FCEB1Q30300020-BC771171-1876-4FB7-A591-3945C48C6809Q30396308-AEF7DF94-0BAC-4F51-904D-1B12BABC6ACEQ33494283-151752A8-626B-44D3-B72A-3894E00C62FAQ33558863-F98701F1-7854-44EB-A11A-2AA38A24DCC4Q33831154-56B83D30-536E-4315-B6AE-DBCB42A59B1FQ33868295-34D1DA5F-F55A-452E-988D-25F9951F1D34Q34046488-EC45E98A-FEE8-493A-838A-95DA5C020756Q34057648-3B7DAFD2-88E3-4F89-BFEA-83B09F96BB9FQ34057927-09305073-48C7-49E5-BB4D-DA74EF214E97Q34163308-B5353219-2692-4C5C-941E-B6DEFE060CB4Q34783330-3FC4D50B-082F-4F08-9040-AD1E594B6FD2Q34983031-4CDA02CA-6758-4F24-B338-A7C59D06C747Q35764055-A09297EF-06D7-4667-99A8-43DE2D4E937DQ35877692-329C51B3-6A04-4FD0-BBE0-D57345B41213Q36277099-13B9A223-26C2-4C7D-AAC0-61C5F5ECA95CQ36337074-5088BDA0-2724-4402-A42A-0F9BCC4C72F5Q36505381-A734A57B-61F0-4432-870E-8B6013A33FE9Q36513085-14B01463-DB31-4217-9B5A-D53911BAC83CQ36544359-511E010A-454D-4603-B164-74D498849B6DQ36558824-DC9EF5DF-D01D-49D5-B399-DDA8AEB093CFQ36607290-F2CB0464-1D75-4CB4-943C-F8441039CECCQ36683661-063E95CC-C541-4E9D-BD41-6AB8C6DEE067Q36910650-A1E0EEB8-51D2-4AD8-B50B-57F2D4298D28Q37204201-72E862AD-485B-4E76-BE72-1AA1D6B5C5CBQ37214101-E515D7EA-1AAC-4C64-B14B-AAF9B1BF94EDQ37220795-047338A6-7A74-4EE4-B006-F66E424FCB59Q37247785-A1A3FF22-B792-45B1-A3FB-651335CF2BEBQ37247793-2A2197FF-FAFC-42AF-A447-86860A19A9B6Q37264321-167879C7-3FE6-4554-96A2-945D44AD0223Q37280926-42372FA7-9B66-4C30-A032-85A4D45798F4Q37335855-00958F64-BA73-4080-A76D-DBFBC2AE24D2Q37430606-B6EA1875-A994-4884-A1FC-DB29B9BBE6A3Q37562416-2737D7E7-8143-49C2-B873-AE1C51969C60Q37562424-E1A0C69B-B66F-4227-8A5C-9D3753AA524AQ37979685-F61F7CDC-B185-4E78-B077-F9A77C5E2C80Q37998398-94A9AD62-7BAE-481E-9993-91A7A06A7598
P2860
European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
European emergence of ciproflo ...... quired uncomplicated cystitis.
@en
type
label
European emergence of ciproflo ...... quired uncomplicated cystitis.
@en
prefLabel
European emergence of ciproflo ...... quired uncomplicated cystitis.
@en
P2093
P2860
P356
P1476
European emergence of ciproflo ...... quired uncomplicated cystitis.
@en
P2093
Anna Marchese
Eugenio Debbia
Gian Carlo Schito
Laura Gualco
Simone Cagnacci
P2860
P304
P356
10.1128/JCM.00640-08
P407
P577
2008-06-25T00:00:00Z